CCA
REGN icon

Criterion Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Criterion Capital Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		$44.1K Hold
42
– – 0.03% 146
2024
Q3 		$44.1K Hold
42
– – 0.03% 146
2024
Q2 		$44.1K Hold
42
– – 0.03% 146
2024
Q1 		$40.4K Hold
42
– – 0.03% 150
2023
Q4 		$36.9K Buy
+42
New +$36.9K 0.03% 163